Kalehua Capital Management LLC
Q4 2025 13F Holdings
- Locationdallas, TX
- Num holdings
19
- Value ($000)
$101,100
- Date Filed02/13/2026
- Form type13F-HR
- CIK0002106181
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 to
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
Alpha Architect 1-3 Month Box Etf | ALPHA ARCH 1-3 | 02072L565 | $26.56M | 26 % | 230,787 | ||
X4 Pharmaceuticals Inc | COM NEW | 98420X202 | $14.89M | 15 % | 3,722,840 | ||
Sionna Therapeutics Inc | COM | 829401108 | $8.11M | 8 % | 197,072 | ||
Relay Therapeutics Inc | COM | 75943R102 | $7.63M | 8 % | 901,457 | ||
Compass Pathways Plc | SPONSORED ADS | 20451W101 | $5.66M | 6 % | 819,692 | ||
Pharvaris NV | COM | N69605108 | $5.52M | 6 % | 198,772 | ||
Septerna Inc | COM | 81734D104 | $5.42M | 5 % | 194,544 | ||
Oruka Therapeutics Inc | COM | 687604108 | $3.59M | 4 % | 118,524 | ||
Inhibikase Therapeutics Inc | COM NEW | 45719W205 | $3.59M | 4 % | 1,750,000 | ||
Allogene Therapeutics Inc | COM | 019770106 | $3.49M | 4 % | 2,546,129 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100